Goldman Sachs earnings preview: Trading through turmoil

Financial companies take centre stage in earnings season this week and Goldman Sachs’ results on Wednesday will be closely watched by the investment community after three months of surging bond sales and a booming stock market comeback. Revenues for the New York-based investment bank are expected to come in a range between $9.3bn and $9.8bn,…

NYSE exchange

U.S. Stock Futures Fall Behind as Investors Turn to the Safety of Government Bonds

Results from the latest trading session point to investors moving away from U.S. stock futures towards the safety of government bonds as jitters mounted about the recovery from Covid-19 lockdowns. Stock futures linked to the S&P 500 were down 0.4%. European stocks traded slightly higher, with the Stoxx Europe 600 index up 0.3%. Asian markets…

us china relations

Outlook for the Chinese Yuan Worsens, prompts the government to look at Reconciliation with the US

After US-China relations soured this year to the lowest level ever, the on-going tension left the Chinese yuan further from a ‘safe-haven’ asset. As the outlook of the yuan against the US Dollar worsened, China seems to be looking at reconciliation. There have been several flashpoints between the United States and China this year including…

Markets react to Weakened US Dollar due to Risk Aversion, Pandemic Fears

US dollar weakened today amid concerns over economic recovery, the slump in energy markets, and rising infections due to the pandemic. Major Asian markets barring those in China closed with losses today while European markets were trading in red in early trade today. US stock markets also closed with significant losses yesterday and futures are…

US primed for bull market despite virus spikes and White House battles, says strategist

Tony Dwyer, chief market strategist Canaccord Genuity believes S&P 500 is in bull market territory, despite admitting that stocks face greater risks in the second half of the year. The S&P 500 rose almost 20% in the second quarter, recording its best quarter since 1998. The index is now down only 4% for the year…

Nasdaq’s $1.2trn biotech index draws Europe’s coronavirus vaccine hunters

As the race towards developing a vaccine for COVID-19 intensifies, Spanish Pharma Mar (PHMR.MC) has become the latest biotech company looking at listing on New York’s Nasdaq market. If this happens it will join a growing number of biotech companies aiming to capitalize on investors’ interest in the booming sector as it tests one of…